STOCK TITAN

Insider schedules 2,210-share issuer (NASDAQ: ANAB) sale under Rule 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of the issuer’s common stock has filed a Rule 144 notice to sell 2,210 shares through Morgan Stanley Smith Barney, with an aggregate market value of $99,914.10. The filing lists 27,688,470 shares of common stock outstanding and targets an approximate sale date of 01/08/2026 on the NASDAQ market.

The 2,210 shares were acquired on 01/08/2026 as restricted stock units from the issuer, paid for in cash. Over the prior three months, the seller, identified as Eric J. Loumeau, reported multiple sales of the issuer’s common stock, including several transactions of 10,000 shares in December 2025 and additional sales in January 2026, each with disclosed gross proceeds.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many ANAB shares are covered by this Rule 144 sale notice?

The notice covers the planned sale of 2,210 shares of the issuer’s common stock, with an aggregate market value of $99,914.10 as stated in the filing.

When are the 2,210 ANAB shares expected to be sold and on which exchange?

The approximate date of sale listed is 01/08/2026, and the shares are to be sold on the NASDAQ exchange.

How were the 2,210 ANAB shares being sold under Rule 144 acquired?

The filing states the 2,210 shares were acquired on 01/08/2026 as restricted stock units from the issuer, with the purchase price paid in cash.

Who is the seller in this ANAB Rule 144 filing and which broker is used?

The seller is identified as Eric J. Loumeau, and the broker listed for the transaction is Morgan Stanley Smith Barney LLC Executive Financial Services at 1 New York Plaza, New York, NY 10004.

What prior ANAB share sales has the seller reported in the last 3 months?

Over the past three months, Eric J. Loumeau reported multiple sales of the issuer’s common stock, including 10,000-share transactions on 12/22/2025 and 12/17/2025, a 12,500-share sale on 12/16/2025, and several smaller sales in December 2025 and January 2026, each with disclosed gross proceeds.

How many ANAB common shares are outstanding according to this Rule 144 notice?

The filing reports that 27,688,470 shares of the issuer’s common stock were outstanding, providing a baseline share count alongside the planned Rule 144 sale.

What does a Rule 144 filing like this indicate for ANAB stock?

A Rule 144 filing indicates that a holder of restricted or control securities of the issuer plans to sell shares, disclosing details such as the number of shares, acquisition method, broker, and recent sales history.

Anaptysbio Inc

NASDAQ:ANAB

ANAB Rankings

ANAB Latest News

ANAB Latest SEC Filings

ANAB Stock Data

1.40B
26.01M
5.82%
124.31%
34.67%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO